Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mannkind Corp
(NQ:
MNKD
)
4.320
+0.010 (+0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Mannkind Corp
< Previous
1
2
Next >
MannKind Corporation to Participate in Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results
February 23, 2023
Conference Call to Begin Today at 5:00 p.m. (ET)
From
MannKind
Via
GlobeNewswire
MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference
February 22, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023
February 16, 2023
From
MannKind
Via
GlobeNewswire
Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference
February 10, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Participate in the Lytham Partners Investor Select Conference
January 24, 2023
From
MannKind
Via
GlobeNewswire
MannKind’s Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease
January 23, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
MannKind
Via
GlobeNewswire
MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting
November 10, 2022
From
MannKind
Via
GlobeNewswire
MannKind Corporation Reports 2022 Third Quarter Financial Results
November 08, 2022
Conference Call to Begin Today at 9:00 a.m. (ET)
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022
November 01, 2022
From
MannKind
Via
GlobeNewswire
The Autism Spectrum Disorders (ASD) Market Is Projected To Reach $4.53 Billion By 2026
May 12, 2021
Via
FinancialNewsMedia
Global Brain Tumor Diagnosis & Treatment Market Could Exceed $880 Million By 2027
June 29, 2021
Via
FinancialNewsMedia
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.